What to expect in the BIOCRYST PHARMACEUTICALS INC interview process

Based on publicly available sources, BioCryst Pharmaceuticals, Inc. is a commercial-stage biotechnology research company founded in 1986, with annual revenue in the $800M–$900M range and a market cap between $1B and $2B. The company employs roughly 400 to 500 people globally across 19 countries, maintaining a workforce decline of around 3% to 4% year-over-year.

BioCryst operates across multiple core locations, featuring a global headquarters in Durham, North Carolina, a European headquarters in Dublin, Ireland, a Discovery Center of Excellence in Birmingham, Alabama, and a regional office in Boston, Massachusetts. Its scientific work centers on structure-guided drug design to develop oral small-molecule medicines and injectable protein therapeutics for rare diseases, particularly hereditary angioedema (HAE).

Regarding hiring activity, data indicates active recruitment with a recent drop in active job postings. Employee feedback from roles such as laboratory technicians points to a mission-driven, highly collaborative environment focused on rare diseases, where precise calculations, timing, and close attention to detail are critical to daily lab work. While the underlying mission and supportive management are frequently cited positives, specific logistical challenges—such as a one-hour daily commute reported by some lab staff in Alabama—can impact the day-to-day experience. The company emphasizes a culture of engagement, accountability, and innovation that encourages employee input toward achieving core objectives.